News
Rocket Lab's high-margin data networks and Neutron's potential $5.6B revenue could drive growth. Click here to read an ...
NASA officials remain eager for Starliner to begin these regular crew rotation flights, even as its sole destination, the ISS ...
Rooted in Varda’s early photography, the Musée Carnavalet’s show illuminates and clarifies the singular nature of a great ...
The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...
The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.
Varda Space Industries, which is leveraging reusable rockets to manufacture drugs in low Earth orbit, has received more fuel for its endeavors in the form of a $187 million series C fundraising haul.
What once seemed like science fiction is quickly becoming an investable reality. The space economy, long dominated by defense ...
Firefly Aerospace has filed paperwork to go public, part of a trend of space companies taking traditional approaches to public markets.
Varda Space Industries has secured $187 million from investors, including Natural Capital and Shrug Capital, to advance its ...
Varda Space Industries has announced a successful $187 million funding round, led by Natural Capital and Shrug Capital. The ...
Varda Space Industries, a company developing spacecraft for microgravity life sciences and hypersonics research, has raised ...
Varda Space Industries has raised $187 million to accelerate drug development in space using microgravity technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results